Z16.35 Resistance to multiple antimicrobial drugs

Name of the Condition

• Resistance to multiple antimicrobial drugs (ICD-10-CM Code: Z16.35)

Summary

Resistance to multiple antimicrobial drugs is a condition where bacteria or other microorganisms develop the ability to withstand the effects of multiple classes of antimicrobial agents. This resistance can severely limit treatment options for infections, as affected organisms may no longer respond to standard or alternative therapies.

Causes

The primary cause is genetic changes in microorganisms that reduce antimicrobial effectiveness. These changes may include enzyme production that inactivates drugs, altered drug targets, or reduced drug uptake. Resistance can develop due to selective pressure from antimicrobial use or horizontal gene transfer between microorganisms.

Risk Factors

• Previous or prolonged use of multiple antimicrobial classes.
• Hospitalization, particularly in intensive care units.
• Weakened immune system from underlying conditions or treatments.
• Presence of invasive medical devices (e.g., catheters, ventilators).
• Exposure to healthcare environments with high resistance rates.

Symptoms

Resistance itself does not cause symptoms, but infections with resistant organisms may present typical infection signs such as fever, pain, swelling, or discharge at the infection site, depending on the affected area.

Diagnosis

Diagnosis involves laboratory testing to identify resistant organisms, typically through culture and susceptibility testing. Molecular methods may also detect resistance genes. Documentation should specify the number and classes of antimicrobials to which resistance is present.

Treatment Options

Treatment requires selecting antimicrobials to which the organism remains susceptible, often guided by susceptibility reports. Options may include newer agents, combination therapy, or alternative classes. Supportive care and infection control measures are also critical.

Prognosis and Follow-Up

Prognosis depends on the infection site, organism, and available treatment options. Follow-up involves monitoring for treatment response and repeat testing if needed. Infections with multidrug-resistant organisms may have higher morbidity and mortality rates.

Complications

Complications include treatment failure, prolonged illness, increased healthcare costs, and spread of resistant organisms to others. Severe infections may lead to organ damage or sepsis.

Lifestyle & Prevention

Preventive measures include appropriate antimicrobial use, hand hygiene, and infection control in healthcare settings. Patients should complete prescribed courses and avoid sharing medications.

When to Seek Professional Help

Seek care if infection symptoms worsen or persist despite treatment, or if new symptoms (e.g., fever, severe pain) develop. Early evaluation is important for resistant infections.

Tips for Medical Coders

Document the specific antimicrobial classes involved in resistance. Ensure the code Z16.35 is used when resistance to multiple antimicrobial drugs is confirmed. Include details on testing methods and organism identification in the medical record for accurate coding.